GO:0044822 | poly(A) RNA binding | 3.86e-05 | 5.57e-01 | 3.286 | 5 | 50 | 1056 |
GO:0008380 | RNA splicing | 1.30e-04 | 1.00e+00 | 4.761 | 3 | 22 | 228 |
GO:0006422 | aspartyl-tRNA aminoacylation | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0048199 | vesicle targeting, to, from or within Golgi | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0035063 | nuclear speck organization | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:1902003 | regulation of beta-amyloid formation | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0035964 | COPI-coated vesicle budding | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0070765 | gamma-secretase complex | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:0004815 | aspartate-tRNA ligase activity | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:0060913 | cardiac cell fate determination | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0035459 | cargo loading into vesicle | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 4 |
GO:0004046 | aminoacylase activity | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 4 |
GO:0030137 | COPI-coated vesicle | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 4 |
GO:0005515 | protein binding | 2.21e-03 | 1.00e+00 | 1.260 | 7 | 198 | 6024 |
GO:0001714 | endodermal cell fate specification | 2.42e-03 | 1.00e+00 | 8.687 | 1 | 1 | 5 |
GO:0043279 | response to alkaloid | 2.42e-03 | 1.00e+00 | 8.687 | 1 | 2 | 5 |
GO:0016607 | nuclear speck | 2.85e-03 | 1.00e+00 | 4.582 | 2 | 12 | 172 |
GO:0048024 | regulation of mRNA splicing, via spliceosome | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 6 |
GO:0010467 | gene expression | 3.02e-03 | 1.00e+00 | 3.208 | 3 | 45 | 669 |
GO:0035413 | positive regulation of catenin import into nucleus | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 2 | 10 |
GO:0042589 | zymogen granule membrane | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 10 |
GO:0045055 | regulated secretory pathway | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 10 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 4 | 11 |
GO:0030667 | secretory granule membrane | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 2 | 12 |
GO:0005838 | proteasome regulatory particle | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 12 |
GO:0030140 | trans-Golgi network transport vesicle | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 12 |
GO:0030234 | enzyme regulator activity | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 2 | 13 |
GO:0048205 | COPI coating of Golgi vesicle | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 1 | 13 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 2 | 13 |
GO:0005685 | U1 snRNP | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 1 | 14 |
GO:0048208 | COPII vesicle coating | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 1 | 15 |
GO:0006376 | mRNA splice site selection | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 1 | 15 |
GO:0001824 | blastocyst development | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 2 | 15 |
GO:0043274 | phospholipase binding | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 16 |
GO:0042176 | regulation of protein catabolic process | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 2 | 16 |
GO:0022624 | proteasome accessory complex | 8.22e-03 | 1.00e+00 | 6.921 | 1 | 1 | 17 |
GO:0045070 | positive regulation of viral genome replication | 8.22e-03 | 1.00e+00 | 6.921 | 1 | 1 | 17 |
GO:0071889 | 14-3-3 protein binding | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 2 | 18 |
GO:0000245 | spliceosomal complex assembly | 1.01e-02 | 1.00e+00 | 6.616 | 1 | 2 | 21 |
GO:0045787 | positive regulation of cell cycle | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 2 | 22 |
GO:0005654 | nucleoplasm | 1.17e-02 | 1.00e+00 | 2.514 | 3 | 64 | 1082 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 1 | 25 |
GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane | 1.30e-02 | 1.00e+00 | 6.254 | 1 | 1 | 27 |
GO:0030658 | transport vesicle membrane | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 1 | 32 |
GO:0005801 | cis-Golgi network | 1.59e-02 | 1.00e+00 | 5.964 | 1 | 1 | 33 |
GO:0019905 | syntaxin binding | 1.59e-02 | 1.00e+00 | 5.964 | 1 | 2 | 33 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.60e-02 | 1.00e+00 | 3.298 | 2 | 30 | 419 |
GO:0045071 | negative regulation of viral genome replication | 1.64e-02 | 1.00e+00 | 5.921 | 1 | 1 | 34 |
GO:0051259 | protein oligomerization | 1.88e-02 | 1.00e+00 | 5.723 | 1 | 2 | 39 |
GO:0035019 | somatic stem cell maintenance | 1.93e-02 | 1.00e+00 | 5.687 | 1 | 6 | 40 |
GO:0006418 | tRNA aminoacylation for protein translation | 2.02e-02 | 1.00e+00 | 5.616 | 1 | 3 | 42 |
GO:0031124 | mRNA 3'-end processing | 2.02e-02 | 1.00e+00 | 5.616 | 1 | 2 | 42 |
GO:0006369 | termination of RNA polymerase II transcription | 2.16e-02 | 1.00e+00 | 5.517 | 1 | 2 | 45 |
GO:0043525 | positive regulation of neuron apoptotic process | 2.21e-02 | 1.00e+00 | 5.485 | 1 | 4 | 46 |
GO:0007030 | Golgi organization | 2.35e-02 | 1.00e+00 | 5.394 | 1 | 3 | 49 |
GO:0006521 | regulation of cellular amino acid metabolic process | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 1 | 50 |
GO:0009611 | response to wounding | 2.50e-02 | 1.00e+00 | 5.308 | 1 | 5 | 52 |
GO:0006888 | ER to Golgi vesicle-mediated transport | 2.54e-02 | 1.00e+00 | 5.281 | 1 | 1 | 53 |
GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment | 2.69e-02 | 1.00e+00 | 5.201 | 1 | 2 | 56 |
GO:0000502 | proteasome complex | 2.78e-02 | 1.00e+00 | 5.151 | 1 | 3 | 58 |
GO:0006406 | mRNA export from nucleus | 2.92e-02 | 1.00e+00 | 5.078 | 1 | 4 | 61 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 3.07e-02 | 1.00e+00 | 5.009 | 1 | 1 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.11e-02 | 1.00e+00 | 4.986 | 1 | 2 | 65 |
GO:0010468 | regulation of gene expression | 3.25e-02 | 1.00e+00 | 4.921 | 1 | 2 | 68 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.35e-02 | 1.00e+00 | 4.879 | 1 | 2 | 70 |
GO:0003729 | mRNA binding | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 4 | 72 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 1 | 72 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 3.54e-02 | 1.00e+00 | 4.799 | 1 | 4 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.54e-02 | 1.00e+00 | 4.799 | 1 | 2 | 74 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 1 | 75 |
GO:0001822 | kidney development | 3.73e-02 | 1.00e+00 | 4.723 | 1 | 3 | 78 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 3.77e-02 | 1.00e+00 | 4.705 | 1 | 2 | 79 |
GO:0009653 | anatomical structure morphogenesis | 3.96e-02 | 1.00e+00 | 4.634 | 1 | 2 | 83 |
GO:0042470 | melanosome | 4.33e-02 | 1.00e+00 | 4.501 | 1 | 2 | 91 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 4.38e-02 | 1.00e+00 | 4.485 | 1 | 1 | 92 |
GO:0006461 | protein complex assembly | 5.27e-02 | 1.00e+00 | 4.214 | 1 | 4 | 111 |
GO:0000209 | protein polyubiquitination | 5.50e-02 | 1.00e+00 | 4.151 | 1 | 3 | 116 |
GO:0010628 | positive regulation of gene expression | 6.88e-02 | 1.00e+00 | 3.819 | 1 | 7 | 146 |
GO:0000082 | G1/S transition of mitotic cell cycle | 7.01e-02 | 1.00e+00 | 3.790 | 1 | 3 | 149 |
GO:0042981 | regulation of apoptotic process | 7.06e-02 | 1.00e+00 | 3.780 | 1 | 4 | 150 |
GO:0000287 | magnesium ion binding | 7.69e-02 | 1.00e+00 | 3.651 | 1 | 4 | 164 |
GO:0000398 | mRNA splicing, via spliceosome | 7.69e-02 | 1.00e+00 | 3.651 | 1 | 15 | 164 |
GO:0044212 | transcription regulatory region DNA binding | 7.88e-02 | 1.00e+00 | 3.616 | 1 | 17 | 168 |
GO:0006886 | intracellular protein transport | 8.01e-02 | 1.00e+00 | 3.591 | 1 | 4 | 171 |
GO:0034641 | cellular nitrogen compound metabolic process | 8.01e-02 | 1.00e+00 | 3.591 | 1 | 2 | 171 |
GO:0005737 | cytoplasm | 8.13e-02 | 1.00e+00 | 1.130 | 4 | 124 | 3767 |
GO:0005667 | transcription factor complex | 8.19e-02 | 1.00e+00 | 3.558 | 1 | 17 | 175 |
GO:0031625 | ubiquitin protein ligase binding | 8.33e-02 | 1.00e+00 | 3.533 | 1 | 5 | 178 |
GO:0032403 | protein complex binding | 8.55e-02 | 1.00e+00 | 3.493 | 1 | 6 | 183 |
GO:0001525 | angiogenesis | 8.91e-02 | 1.00e+00 | 3.431 | 1 | 7 | 191 |
GO:0070062 | extracellular vesicular exosome | 9.54e-02 | 1.00e+00 | 1.365 | 3 | 57 | 2400 |
GO:0016071 | mRNA metabolic process | 1.03e-01 | 1.00e+00 | 3.208 | 1 | 8 | 223 |
GO:0005829 | cytosol | 1.05e-01 | 1.00e+00 | 1.308 | 3 | 86 | 2496 |
GO:0006412 | translation | 1.06e-01 | 1.00e+00 | 3.163 | 1 | 8 | 230 |
GO:0008134 | transcription factor binding | 1.12e-01 | 1.00e+00 | 3.090 | 1 | 18 | 242 |
GO:0003677 | DNA binding | 1.13e-01 | 1.00e+00 | 1.758 | 2 | 49 | 1218 |
GO:0016070 | RNA metabolic process | 1.14e-01 | 1.00e+00 | 3.060 | 1 | 8 | 247 |
GO:0000166 | nucleotide binding | 1.19e-01 | 1.00e+00 | 2.992 | 1 | 13 | 259 |
GO:0005524 | ATP binding | 1.25e-01 | 1.00e+00 | 1.667 | 2 | 31 | 1298 |
GO:0030154 | cell differentiation | 1.37e-01 | 1.00e+00 | 2.775 | 1 | 5 | 301 |
GO:0035556 | intracellular signal transduction | 1.38e-01 | 1.00e+00 | 2.766 | 1 | 9 | 303 |
GO:0004674 | protein serine/threonine kinase activity | 1.40e-01 | 1.00e+00 | 2.742 | 1 | 6 | 308 |
GO:0003723 | RNA binding | 1.55e-01 | 1.00e+00 | 2.591 | 1 | 18 | 342 |
GO:0043565 | sequence-specific DNA binding | 1.56e-01 | 1.00e+00 | 2.574 | 1 | 11 | 346 |
GO:0000139 | Golgi membrane | 1.63e-01 | 1.00e+00 | 2.513 | 1 | 7 | 361 |
GO:0005925 | focal adhesion | 1.65e-01 | 1.00e+00 | 2.493 | 1 | 9 | 366 |
GO:0008284 | positive regulation of cell proliferation | 1.71e-01 | 1.00e+00 | 2.431 | 1 | 10 | 382 |
GO:0000278 | mitotic cell cycle | 1.75e-01 | 1.00e+00 | 2.398 | 1 | 15 | 391 |
GO:0005730 | nucleolus | 1.85e-01 | 1.00e+00 | 1.328 | 2 | 66 | 1641 |
GO:0043066 | negative regulation of apoptotic process | 1.89e-01 | 1.00e+00 | 2.281 | 1 | 16 | 424 |
GO:0016020 | membrane | 1.92e-01 | 1.00e+00 | 1.294 | 2 | 46 | 1681 |
GO:0006468 | protein phosphorylation | 2.03e-01 | 1.00e+00 | 2.163 | 1 | 10 | 460 |
GO:0016032 | viral process | 2.32e-01 | 1.00e+00 | 1.948 | 1 | 26 | 534 |
GO:0006915 | apoptotic process | 2.40e-01 | 1.00e+00 | 1.892 | 1 | 12 | 555 |
GO:0005783 | endoplasmic reticulum | 2.41e-01 | 1.00e+00 | 1.890 | 1 | 13 | 556 |
GO:0005789 | endoplasmic reticulum membrane | 2.46e-01 | 1.00e+00 | 1.854 | 1 | 9 | 570 |
GO:0045087 | innate immune response | 2.56e-01 | 1.00e+00 | 1.790 | 1 | 15 | 596 |
GO:0005794 | Golgi apparatus | 2.61e-01 | 1.00e+00 | 1.756 | 1 | 9 | 610 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 2.94e-01 | 1.00e+00 | 1.560 | 1 | 39 | 699 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 3.26e-01 | 1.00e+00 | 1.385 | 1 | 41 | 789 |
GO:0005886 | plasma membrane | 3.65e-01 | 1.00e+00 | 0.674 | 2 | 49 | 2582 |
GO:0005634 | nucleus | 3.90e-01 | 1.00e+00 | 0.439 | 3 | 159 | 4559 |
GO:0006355 | regulation of transcription, DNA-templated | 3.94e-01 | 1.00e+00 | 1.047 | 1 | 43 | 997 |
GO:0044281 | small molecule metabolic process | 4.59e-01 | 1.00e+00 | 0.767 | 1 | 20 | 1211 |
GO:0016021 | integral component of membrane | 6.45e-01 | 1.00e+00 | 0.056 | 1 | 17 | 1982 |